Droxidopa

(Northera®)

Droxidopa

Drug updated on 3/28/2024

Dosage FormCapsules (oral: 100 mg, 200 mg, 300 mg)
Drug ClassUnknown mechanism of action
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of orthostatic dizziness and light-headedness or the “feeling that you are about to black out” in adult patients with symptomatic neurogenic orthostatic hypotension (nOH) caused by primary autonomic failure (Parkinson's disease [PD], multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropath